NASDAQ:SPNC - Spectranetics Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $38.45 0.00 (0.00 %) (As of 08/21/2018 05:54 AM ET)Previous Close$38.45Today's Range$38.45 - $38.4552-Week Range$19.80 - $38.55VolumeN/AAverage Volume788,356 shsMarket Capitalization$1.68 billionP/E RatioN/ADividend YieldN/ABeta1.54 Company ProfileAnalyst RatingsChartEarnings HistoryFinancialsInsider TradesHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email The Spectranetics Corporation develops, manufactures, markets and distributes single-use medical devices used in minimally invasive procedures within the cardiovascular system. The Company's products are used to cross, prepare and treat arterial blockages in the heart and legs and to manage pacemaker and defibrillator cardiac leads. Its geographic segments are U.S. Medical and International Medical. Its product offerings in U.S. Medical segment include medical devices used in minimally invasive procedures within the cardiovascular system, including fiber-optic devices and non-fiber-optic products (disposables), an excimer laser system (equipment) and the service of the excimer laser system (service). Its products are used in multiple vascular procedures, including peripheral atherectomy, crossing arterial blockages, coronary atherectomy and thrombectomy. Its International Medical segment is primarily engaged in distribution activities. Receive SPNC News and Ratings via Email Sign-up to receive the latest news and ratings for SPNC and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry N/A Sub-IndustryHealth Care Supplies SectorN/A SymbolNASDAQ:SPNC CUSIP84760C10 Webwww.spectranetics.com Phone+1-719-6338333 Debt Debt-to-Equity Ratio7.61 Current Ratio1.92 Quick Ratio1.43 Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / CashN/A Book ValueN/A Price / BookN/A Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net Margins-32.93% Return on Equity-194.18% Return on Assets-23.25% Miscellaneous Employees960 Outstanding Shares43,850,000Market Cap$1.68 billion Spectranetics (NASDAQ:SPNC) Frequently Asked Questions What is Spectranetics' stock symbol? Spectranetics trades on the NASDAQ under the ticker symbol "SPNC." How were Spectranetics' earnings last quarter? Spectranetics Corp (NASDAQ:SPNC) issued its earnings results on Thursday, August, 3rd. The medical equipment provider reported ($0.56) earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of ($0.27) by $0.29. The medical equipment provider earned $74.71 million during the quarter, compared to analysts' expectations of $73.82 million. Spectranetics had a negative return on equity of 194.18% and a negative net margin of 32.93%. The company's revenue for the quarter was up 10.3% compared to the same quarter last year. During the same quarter in the prior year, the business posted ($0.35) EPS. View Spectranetics' Earnings History. Who are Spectranetics' key executives? Spectranetics' management team includes the folowing people: B. Kristine Johnson, Chairman of the Board (Age 65)Scott William Drake, President, Chief Executive Officer, Director (Age 49)Stacy McMahan, Chief Financial Officer (Age 53)Shahriar Matin, Chief Operating Officer (Age 42)Scott Hutton, Senior Vice President and General Manager of Vascular Intervention (Age 45)Donna Ford-Serbu, Senior Vice President - Sales and Marketing of Lead Management (Age 48)William C. Jennings, Independent Director (Age 78)Daniel A. Pelak, Independent Director (Age 65)Joseph M. Ruggio M.D., Independent Director (Age 62)Maria Degois Sainz, Independent Director (Age 51) Has Spectranetics been receiving favorable news coverage? News stories about SPNC stock have trended somewhat positive on Tuesday, according to Accern Sentiment. The research group scores the sentiment of news coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Spectranetics earned a news and rumor sentiment score of 0.16 on Accern's scale. They also assigned news stories about the medical equipment provider an impact score of 47.89 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company's share price in the next several days. View Recent Headlines for Spectranetics. How do I buy shares of Spectranetics? Shares of SPNC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Spectranetics' stock price today? One share of SPNC stock can currently be purchased for approximately $38.45. How big of a company is Spectranetics? Spectranetics has a market capitalization of $1.68 billion. Spectranetics employs 960 workers across the globe. How can I contact Spectranetics? Spectranetics' mailing address is 9965 Federal Dr, COLORADO SPRINGS, CO 80921-3822, United States. The medical equipment provider can be reached via phone at +1-719-6338333. MarketBeat Community Rating for Spectranetics (NASDAQ SPNC)Community Ranking: 3.0 out of 5 ( )Outperform Votes: 338 (Vote Outperform)Underperform Votes: 228 (Vote Underperform)Total Votes: 566MarketBeat's community ratings are surveys of what our community members think about Spectranetics and other stocks. Vote "Outperform" if you believe SPNC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SPNC will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 8/21/2018 by MarketBeat.com StaffFeatured Article: What are Closed-End Mutual Funds?